<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C0805014-A6FD-41C1-81BE-B94AE4139F25"><gtr:id>C0805014-A6FD-41C1-81BE-B94AE4139F25</gtr:id><gtr:name>Max Planck Society</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43"><gtr:id>31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43</gtr:id><gtr:name>Public Health England</gtr:name><gtr:address><gtr:line1>Porton Down</gtr:line1><gtr:line4>Salisbury</gtr:line4><gtr:line5>Wiltshire</gtr:line5><gtr:postCode>SP4 0JG</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/867469FA-33A0-41B9-994B-9CCC45998469"><gtr:id>867469FA-33A0-41B9-994B-9CCC45998469</gtr:id><gtr:name>SH-Gen</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FEABAB9A-B377-49D0-940E-E1841C6DF4CC"><gtr:id>FEABAB9A-B377-49D0-940E-E1841C6DF4CC</gtr:id><gtr:name>Base4 Innovation</gtr:name><gtr:address><gtr:line1>Broers Building</gtr:line1><gtr:line2>21 JJ Thompson Avenue</gtr:line2><gtr:postCode>CB3 0FA</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/AB7C0822-BBCB-4C61-85EC-5D13C7A31759"><gtr:id>AB7C0822-BBCB-4C61-85EC-5D13C7A31759</gtr:id><gtr:name>MRC Laboratory of Molecular Biology</gtr:name><gtr:address><gtr:line1>Hills Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 2QH</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AB7C0822-BBCB-4C61-85EC-5D13C7A31759"><gtr:id>AB7C0822-BBCB-4C61-85EC-5D13C7A31759</gtr:id><gtr:name>MRC Laboratory of Molecular Biology</gtr:name><gtr:address><gtr:line1>Hills Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 2QH</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C0805014-A6FD-41C1-81BE-B94AE4139F25"><gtr:id>C0805014-A6FD-41C1-81BE-B94AE4139F25</gtr:id><gtr:name>Max Planck Society</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43"><gtr:id>31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43</gtr:id><gtr:name>Public Health England</gtr:name><gtr:address><gtr:line1>Porton Down</gtr:line1><gtr:line4>Salisbury</gtr:line4><gtr:line5>Wiltshire</gtr:line5><gtr:postCode>SP4 0JG</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/867469FA-33A0-41B9-994B-9CCC45998469"><gtr:id>867469FA-33A0-41B9-994B-9CCC45998469</gtr:id><gtr:name>SH-Gen</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FEABAB9A-B377-49D0-940E-E1841C6DF4CC"><gtr:id>FEABAB9A-B377-49D0-940E-E1841C6DF4CC</gtr:id><gtr:name>Base4 Innovation</gtr:name><gtr:address><gtr:line1>Broers Building</gtr:line1><gtr:line2>21 JJ Thompson Avenue</gtr:line2><gtr:postCode>CB3 0FA</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/B168F1C5-49EB-41F9-8B3D-A7FD38EF3B40"><gtr:id>B168F1C5-49EB-41F9-8B3D-A7FD38EF3B40</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:surname>Dear</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U105131672"><gtr:id>1728DE67-3BDA-4976-82F4-C8FEDB002BC6</gtr:id><gtr:title>Single molecule genomics</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U105131672</gtr:grantReference><gtr:abstractText>My group works on ways to analyse DNA the genetic material. Most methods analyse large DNA samples, which have to be produced by cloning or other methods. instead, we concentrate on analysing single DNA molecules. We have developed a range of techniques with this theme. Recently, we have devised a way to look for copy-number changes: mutations or natural variations which lead to extra copies or missing copies of some pieces of DNA. This method has proved valuable in analysing the changes that happen in the genome during the development of cancer. |We are also developing microfluidic tools: miniaturized analytical devices based around glass chips containing minute tubes, mixing chambers and other scaled-down versions of laboratory equipment. With these devices, we intend to streamline and automate the analysis of copy-number changes. We are also working on ways to sequence (that is, to read) large pieces of DNA quickly, again using microfluidic tools.</gtr:abstractText><gtr:technicalSummary>Our focus is on developing and applying new methods of analysing the genome. Our approaches revolve around the analysis of single DNA molecules, for which we have developed a range of techniques.|Single-molecule methods simplify many aspects of genome analysis. Not only is it unnecessary to purify a genomic fragment by cloning (since a single molecule is always pure), but we can readily access aspects of genomic variation which are masked by analysing bulk samples. |Recently, we developed a method for accurately measuring copy-number variations which arise either in cancer (for example, as a result of non-reciprocal translocations or regional genomic amplification), or as part of the normal spectrum of variation. In essence, we just count the number of molecules of a given target sequence in very dilute DNA samples. The approach is robust and sensitive, and can be applied to even minute amounts of material. Ongoing work as shown that we can use this method to obtain otherwise inaccessible information on the genomic changes that happen in the earliest stages of lung cancer. Other, collaborative projects are focussed on breast and colorectal cancers, and other groups have also adopted the method.|We are also developing microfluidic tools for genomic analysis. One of these, a single-chip copy-number device, will greatly streamline and accelerate our existing method for measuring copy-number, allowing a compact device to give accurate and rapid copy-number measurements in minutes. A second device, whose development will take longer, will enable us to sequence large (&amp;gt;&amp;gt;10kb) fragments of genomic DNA rapidly and cheaply, in contrast to traditional Sanger sequencing or to sequence tag methods such as 454 and Solexa.</gtr:technicalSummary><gtr:fund><gtr:end>2010-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1994-10-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>2892990</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Public Health England</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Detection and identification of human pathogens and parasites</gtr:description><gtr:id>BAD81CD0-9DD4-400D-A6EE-A26AF66E8818</gtr:id><gtr:impact>Yes</gtr:impact><gtr:outcomeId>TG8BFwQgknM-1</gtr:outcomeId><gtr:partnerContribution>Yes</gtr:partnerContribution><gtr:piContribution>Shortly before being made redundant by the MRC, I devised a sensitive diagnostic for neonatal meningitis. This is now being trialled at Addenbrooke's and in Cardiff.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Base4 Innovation</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Development of novel sequencing technology</gtr:description><gtr:id>71FAC1D2-CE72-41AC-BDEB-34B4E68FC9E4</gtr:id><gtr:impact>Yes</gtr:impact><gtr:outcomeId>tP2vyYrYpGy-1</gtr:outcomeId><gtr:partnerContribution>Base4 has increased its commitment to this project, with approx. 40 employees full-time.</gtr:partnerContribution><gtr:piContribution>Since my redundancy from MRC in April 2015, I have continued to develop this technology, which is now the sole activity of a 40-strong biotech company in Cambridge.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Max Planck Society</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Analysis of ancient DNA</gtr:description><gtr:id>A3BC21D4-04D8-4D21-9098-AB82613C707B</gtr:id><gtr:impact>Publications. More generally, our methods are now commonly used in the analysis of ancient DNA.</gtr:impact><gtr:outcomeId>nuq9vQdngv7-1</gtr:outcomeId><gtr:partnerContribution>Developed techniques for analysing multiple sequences from fossil specimens (mammoth, Neanderthal)</gtr:partnerContribution><gtr:piContribution>Development and implementation of methods for analysing DNA in ancient specimens</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>SH-Gen</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Pre-fertilisation diagnosis</gtr:description><gtr:id>081BCBF7-52FC-4602-852F-69D1CE06D88F</gtr:id><gtr:impact>Currently in use. The main outputs are babies.</gtr:impact><gtr:outcomeId>gmNS4YV1F1G-1</gtr:outcomeId><gtr:partnerContribution>Yes</gtr:partnerContribution><gtr:piContribution>Since my redundancy from MRC in 2015, this work has led to clinical applications; it is now being offered to patients at one of Germany's leading fertility centres, and is proving uniquely effective in improving the pregnancy rates from IVF.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Teaching/mentoring/advising - Malaysia</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>EB0AE7D7-3C39-41B5-9C95-D9D3AD01AB28</gtr:id><gtr:impact>I teach and mentor regularly at the Universiti Kebangsaan, Malaysia. I teach a workshop in scientific paper writing, and also a workshop in science strategy and innovation (both to postgraduates, and postdocs). I also periodically advise senior officials of the University and (less often) Malaysia's science ministry. This takes place annually.

See above.</gtr:impact><gtr:outcomeId>iVLRpPRPGLz</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2008,2009,2010,2011,2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>Method for analysing changes in copy-number in DNA</gtr:description><gtr:grantRef>MC_U105131672</gtr:grantRef><gtr:id>AA76B618-B009-47A4-B38E-9DBA6146D396</gtr:id><gtr:impact>Identification of driver genes in colon and lung cancer.</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>Uek5TsWURgj</gtr:outcomeId><gtr:patentId>ES2337207</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Molecular Copy-number counting</gtr:title><gtr:yearProtectionGranted>2010</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>I invented a new sequencing technology. A contract has been signed with Cambridge-based company Base4 for the joint development of this technology; this contract covers mutual confidentiality agreements and the terms for handling IP, which is being filed jointly by Base4 and MRC.</gtr:description><gtr:grantRef>MC_U105131672</gtr:grantRef><gtr:id>FBDB9877-5F37-4CCA-88F1-F3CCD68116D9</gtr:id><gtr:impact>Main impact is that I am currently seconded to Base4 to assist with development.</gtr:impact><gtr:licensed>Commercial In Confidence</gtr:licensed><gtr:outcomeId>raDNt9xhiY9</gtr:outcomeId><gtr:protection>Protection not required</gtr:protection><gtr:title>New sequencing technology.</gtr:title><gtr:yearProtectionGranted>2012</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Research strategies in Malaysia</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>1CD6DB66-E574-468C-A985-C3B64FD14F4D</gtr:id><gtr:impact>Since 2007, I have been a visiting professor for 1-2 weeks per year in Malaysia. This has involved reviews of their research programs and discussions with their Science Minister and with senior members (deputy VC and below) at one of their leading research universities (UKM). I am trying to foster a more solid base for science in Malaysia which, as a developing nation in which research is still emerging, has the opportunity to follow a more sustainable and productive course than other countries (Singapore, Brazil) which have attempted to become significant players in molecular biology and genomics.
During my latest visit (2011), I have given workshops on research strategy and seminars on the research ethos at LMB. One of my focusses has been to caution them against over-bureaucratization, and to point out that LMB's success over the years has been in spite of, rather than because of, the current Western fashion for evaluation, accountability and quantifiable short-term deliverables.</gtr:impact><gtr:outcomeId>003EBAAC423</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:description>Method allows chromatid-level analysis of aneuploidy in human oocytes prior to fertilisation.</gtr:description><gtr:id>F2BF12A9-AE18-4EC4-95FB-4D8386289CAC</gtr:id><gtr:impact>The method continues to be evaluated by retrospective analysis of human subjects undergoing fertility treatment. 

Update Nov2012: the method is now applied to _prospectively_ to patients undergoing IVF at Europe's largest fertility centre. Early results are successful. I am developing software for the automated interpretation of results.</gtr:impact><gtr:outcomeId>NvzdXjpkbot</gtr:outcomeId><gtr:stage>Early clinical assessment</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Pre-fertilisation diagnostics</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:yearDevCompleted>2009</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:description>(See corresponding entry under IP)</gtr:description><gtr:id>7270B392-042D-4C2E-B0B9-16D74EF72B68</gtr:id><gtr:impact>See above, and corresponding entry under IP. 
I would also like to point out that ResearchFish seems biased toward healthcare/point of care applications, and doesn't always fit with other research.</gtr:impact><gtr:outcomeId>ac3W2JYZqjb</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Sequencing technology</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:yearDevCompleted>2012</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We identified SOX2 as a critical gene in the transition from low-grade dysplasia to pre-cancerous high-grade dysplasia in lung cancer. SOX2 is being further investigated as a potential therapeutic target.</gtr:description><gtr:id>ED9A1E66-C204-410D-B0EF-012C92D41E33</gtr:id><gtr:impact>Ongoing studies on SOX2</gtr:impact><gtr:outcomeId>TJGVGoT2j92</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>SOX2 as a key gene in lung cancer</gtr:title><gtr:type>Model of mechanisms or symptoms - human</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>MCC is a technique which allows analysis of copy-number changes (gains or losses of DNA) in samples which are not tractable to other methods. It is particularly valuable in the accurate, multi-locus analysis of cancer biopsies.</gtr:description><gtr:id>2D65614D-6AD1-4FA8-84BF-65BAF3BD8E7D</gtr:id><gtr:impact>See publications. In my own group, we have used this method to identify an important gene whose amplification is INVARIABLY associated with the development of one common type of lung cancer, and which is a promising target for diagnosis, prognosis and intervention. In collaboration with Daser (University of Mainz), we have developed a method for analysing aneuploidy (uniquely, at the level of individual CHROMATIDS) in human polar bodies, leading to a method of pre-fertilisation diagnosis of oocyte aneuploidy; trials of this method in patients are underway. Patents have been filed for MCC (granted), for a combined assay which couples MCC with multilocus mutational analysis (under way) and for the adaptation of MCC to pre-fertilisation diagnosis (under way)</gtr:impact><gtr:outcomeId>hkEcLo33C3W</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Molecular Copy-number counting</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>I have established a microfluidics fabrication facility at LMB. Use of this facility has been scaled down following the recent quinquennial review, but it will be of use.</gtr:description><gtr:id>801921C5-A650-45D8-AF77-BE515B7E0AFF</gtr:id><gtr:impact>Sequencing platform developed with the aid of this facility is now the subject of commercial exploitation.</gtr:impact><gtr:outcomeId>TBHSgeGHtng</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Microfluidics infrastructure</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>CE8B917A-A30C-40E5-AC1C-4B3B06C82607</gtr:id><gtr:title>Single-molecule genomics.</gtr:title><gtr:parentPublicationTitle>The Journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/571a0cb275300a32e9185f4502768350"><gtr:id>571a0cb275300a32e9185f4502768350</gtr:id><gtr:otherNames>McCaughan F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-3417</gtr:issn><gtr:outcomeId>LZbbXFznws5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F75FB297-84B2-4AE7-B407-68A53D7618D3</gtr:id><gtr:title>Copy-number variation: the end of the human genome?</gtr:title><gtr:parentPublicationTitle>Trends in biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3492e77abfa4fbeddd464f65e8b13d53"><gtr:id>3492e77abfa4fbeddd464f65e8b13d53</gtr:id><gtr:otherNames>Dear PH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0167-7799</gtr:issn><gtr:outcomeId>PaQdChzpx7D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>85F24A22-193F-4E9D-BF76-8208977BBCBA</gtr:id><gtr:title>Mitochondrial genomes reveal an explosive radiation of extinct and extant bears near the Miocene-Pliocene boundary.</gtr:title><gtr:parentPublicationTitle>BMC evolutionary biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b706be357c33cc48fb08126ed2c28617"><gtr:id>b706be357c33cc48fb08126ed2c28617</gtr:id><gtr:otherNames>Krause J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1471-2148</gtr:issn><gtr:outcomeId>D781B78C527</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CB8DE0F8-58C5-44A4-AE86-36746D73BBB2</gtr:id><gtr:title>Real-time PCRs and fingerprinting assays for the detection and characterization of Salmonella Genomic Island-1 encoding multidrug resistance: application to 445 European isolates of Salmonella, Escherichia coli, Shigella, and Proteus.</gtr:title><gtr:parentPublicationTitle>Microbial drug resistance (Larchmont, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5c038e4baefae0165f79cc9f824b84ff"><gtr:id>5c038e4baefae0165f79cc9f824b84ff</gtr:id><gtr:otherNames>Amar CF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1076-6294</gtr:issn><gtr:outcomeId>8DFFAD4C0C9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1DFDE169-D54A-49AE-BD59-BC1D6460D0C6</gtr:id><gtr:title>IRS2 is a candidate driver oncogene on 13q34 in colorectal cancer.</gtr:title><gtr:parentPublicationTitle>International journal of experimental pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6642d4f073513e35e143ada71650af22"><gtr:id>6642d4f073513e35e143ada71650af22</gtr:id><gtr:otherNames>Day E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0959-9673</gtr:issn><gtr:outcomeId>pm_15387_27_23594372</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D13C70D2-A6C2-4B5A-8C65-683A9C17755C</gtr:id><gtr:title>Sequencing and analysis of chromosome 1 of Eimeria tenella reveals a unique segmental organization.</gtr:title><gtr:parentPublicationTitle>Genome research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b6cf04a1838999e0a6eeaf401db4db89"><gtr:id>b6cf04a1838999e0a6eeaf401db4db89</gtr:id><gtr:otherNames>Ling KH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1088-9051</gtr:issn><gtr:outcomeId>44983708FD0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>67543E2D-6831-484C-A94D-4C8DB76FA6FE</gtr:id><gtr:title>Microdissection molecular copy-number counting (microMCC)--unlocking cancer archives with digital PCR.</gtr:title><gtr:parentPublicationTitle>The Journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/571a0cb275300a32e9185f4502768350"><gtr:id>571a0cb275300a32e9185f4502768350</gtr:id><gtr:otherNames>McCaughan F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-3417</gtr:issn><gtr:outcomeId>89FC47C65BC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>95CCC6B2-499F-4473-8251-F50F7EBE0C31</gtr:id><gtr:title>Genomic analysis of the causative agents of coccidiosis in domestic chickens.</gtr:title><gtr:parentPublicationTitle>Genome research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/76790a46896fdc5e977ae7511bde90da"><gtr:id>76790a46896fdc5e977ae7511bde90da</gtr:id><gtr:otherNames>Reid AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1088-9051</gtr:issn><gtr:outcomeId>545b86c5864f22.97213631</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD5F6FD2-D5D5-40CB-89CB-B4A5DDE18355</gtr:id><gtr:title>An efficient method for multi-locus molecular haplotyping.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/04d85d12c95cec94a74b9ea259ee9917"><gtr:id>04d85d12c95cec94a74b9ea259ee9917</gtr:id><gtr:otherNames>Konfortov BA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>09EBE167D98</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C544E2A-9D40-4D5F-9167-F9ACE06EDBFE</gtr:id><gtr:title>Multiplex amplification of ancient DNA.</gtr:title><gtr:parentPublicationTitle>Nature protocols</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f5142e84032c67f389e7ed0ec66a9462"><gtr:id>f5142e84032c67f389e7ed0ec66a9462</gtr:id><gtr:otherNames>R?mpler H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1750-2799</gtr:issn><gtr:outcomeId>2FA233CBD9C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BE686296-1656-48BA-99C0-9D33F436C514</gtr:id><gtr:title>Use of HAPPY mapping for the higher order assembly of the Tetrahymena genome.</gtr:title><gtr:parentPublicationTitle>Genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35c10820e18378a4c16baed152435cf8"><gtr:id>35c10820e18378a4c16baed152435cf8</gtr:id><gtr:otherNames>Hamilton EP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0888-7543</gtr:issn><gtr:outcomeId>A88F0539138</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0FDD9B77-15AA-4DD5-884D-83001420CA48</gtr:id><gtr:title>Digital PCR strategies in the development and analysis of molecular biomarkers for personalized medicine.</gtr:title><gtr:parentPublicationTitle>Methods (San Diego, Calif.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6642d4f073513e35e143ada71650af22"><gtr:id>6642d4f073513e35e143ada71650af22</gtr:id><gtr:otherNames>Day E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1046-2023</gtr:issn><gtr:outcomeId>pm_15387_27_22926236</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>942520F5-68D5-4867-AFB2-8BEF38E6E2AF</gtr:id><gtr:title>Single-molecule analysis of genome rearrangements in cancer.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b201495d9d323e7e841aa5cc0631c3b3"><gtr:id>b201495d9d323e7e841aa5cc0631c3b3</gtr:id><gtr:otherNames>Pole JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>VPWGyn1PmNM</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>037B1896-0A80-4020-B0FA-8867EDAA7321</gtr:id><gtr:title>Genomic evidence of pre-invasive clonal expansion, dispersal and progression in bronchial dysplasia.</gtr:title><gtr:parentPublicationTitle>The Journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/571a0cb275300a32e9185f4502768350"><gtr:id>571a0cb275300a32e9185f4502768350</gtr:id><gtr:otherNames>McCaughan F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-3417</gtr:issn><gtr:outcomeId>spfmnsffp3A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>552E0D9F-DC6B-47A7-BCF5-D8E92DB9AD97</gtr:id><gtr:title>BAC-HAPPY mapping (BAP mapping): a new and efficient protocol for physical mapping.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e02545c58138c06a696da332a348f79d"><gtr:id>e02545c58138c06a696da332a348f79d</gtr:id><gtr:otherNames>Vu GT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>RoeEhNivvgY</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8F7569EE-4388-4056-8AC9-36640E6CEBD2</gtr:id><gtr:title>Progressive 3q amplification consistently targets SOX2 in preinvasive squamous lung cancer.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/571a0cb275300a32e9185f4502768350"><gtr:id>571a0cb275300a32e9185f4502768350</gtr:id><gtr:otherNames>McCaughan F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>Q2vBxp6Ear9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1FFAE704-C1B1-4F4B-AA9E-8F5E93CB9282</gtr:id><gtr:title>Interrogation of genomes by molecular copy-number counting (MCC).</gtr:title><gtr:parentPublicationTitle>Nature methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe3de59f6b1000a2eb68fa245c302cf3"><gtr:id>fe3de59f6b1000a2eb68fa245c302cf3</gtr:id><gtr:otherNames>Daser A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1548-7091</gtr:issn><gtr:outcomeId>c95ppsvBVWm</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>929BA145-FEE3-4B6B-BAE5-648CFCD1F51A</gtr:id><gtr:title>Numts help to reconstruct the demographic history of the ocellated lizard (Lacerta lepida) in a secondary contact zone.</gtr:title><gtr:parentPublicationTitle>Molecular ecology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cc65dee680774308bdf120a0dd3aa930"><gtr:id>cc65dee680774308bdf120a0dd3aa930</gtr:id><gtr:otherNames>Miraldo A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0962-1083</gtr:issn><gtr:outcomeId>pm_15387_27_22221514</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>145ACE04-EACA-45F1-8B3A-471F1E59D1A8</gtr:id><gtr:title>Multiplex amplification of the mammoth mitochondrial genome and the evolution of Elephantidae.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b706be357c33cc48fb08126ed2c28617"><gtr:id>b706be357c33cc48fb08126ed2c28617</gtr:id><gtr:otherNames>Krause J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>BB72EBA4C57</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U105131672</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>